BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36710214)

  • 1. Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Jansson H; Villard C; Nooijen LE; Ghorbani P; Erdmann JI; Sparrelid E
    Eur J Surg Oncol; 2023 Apr; 49(4):688-699. PubMed ID: 36710214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
    Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
    Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
    Lozada ME; Zhang N; Jin W; Wongjarupong N; Yang JD; Voss MM; Prasai K; Amakye DO; Harmsen WS; Chaudhary S; Bathe OF; Borad MJ; Patel TC; Gores GJ; Therneau TM; Roberts LR
    Am J Gastroenterol; 2023 Dec; 118(12):2173-2183. PubMed ID: 36940423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of resection margin width in patients with intrahepatic cholangiocarcinoma: a meta-analysis.
    Dai YS; Hu HJ; Lv TR; Hu YF; Zou RQ; Li FY
    World J Surg Oncol; 2023 Jan; 21(1):16. PubMed ID: 36658564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
    Liao P; Cao L; Chen H; Pang SZ
    Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Holster JJ; El Hassnaoui M; Franssen S; IJzermans JNM; de Jonge J; Mostert B; Polak WG; de Wilde RF; Homs MYV; Groot Koerkamp B
    Ann Surg Oncol; 2022 Sep; 29(9):5528-5538. PubMed ID: 35294656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
    Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
    J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality and performance of validated prognostic models for survival after resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
    Büttner S; Galjart B; Beumer BR; van Vugt JLA; van Eijck CHJ; Polak WG; de Jonge J; Homs MYV; van Driel LMJW; Pawlik TM; Steyerberg EW; Ijzermans JNM; Groot Koerkamp B
    HPB (Oxford); 2021 Jan; 23(1):25-36. PubMed ID: 32855047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors in Intrahepatic Cholangiocarcinoma - A Systematic Review.
    Zgura A; Savin C; Tirca L; Balescu I; Eftimie M; Petrea S; Hasegan A; Gaspar B; Gorecki GP; Martac C; Stoian M; Bacalbasa N
    Chirurgia (Bucur); 2024 Mar; 119(Ahead of print):1-13. PubMed ID: 38484362
    [No Abstract]   [Full Text] [Related]  

  • 12. SUOX and GLUT1 are biomarkers for the prognosis in large duct type intrahepatic cholangiocarcinoma.
    Kinjo Y; Naito Y; Akiba J; Sadashima E; Nakayama M; Tanigawa M; Hisaka T; Okabe Y; Yano H
    Hum Pathol; 2022 Oct; 128():11-19. PubMed ID: 35764144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival.
    Thakral N; Gonzalez T; Nano O; Shin SH; Samuels S; Hussein A
    BMC Gastroenterol; 2023 May; 23(1):151. PubMed ID: 37179301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma.
    Zhang R; Li Q; Fu J; Jin Z; Su J; Zhang J; Chen C; Geng Z; Zhang D
    BMC Cancer; 2021 Feb; 21(1):112. PubMed ID: 33535978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Prognostic Score for Cholangiocarcinoma Patients Using a Combination of Biochemical Parameters.
    Min-Oo HH; Aung TM; Wongwattanakul M; Maraming P; Proungvitaya T; Proungvitaya S
    In Vivo; 2023; 37(3):1145-1155. PubMed ID: 37103102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic upregulation of TET2 is an independent poor prognostic factor for intrahepatic cholangiocarcinoma.
    Yamashita H; Tourna A; Akita M; Itoh T; Chokshi S; Ajiki T; Fukumoto T; Youngson NA; Zen Y
    Virchows Arch; 2022 May; 480(5):1077-1085. PubMed ID: 34905094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
    Dong L; Lu D; Chen R; Lin Y; Zhu H; Zhang Z; Cai S; Cui P; Song G; Rao D; Yi X; Wu Y; Song N; Liu F; Zou Y; Zhang S; Zhang X; Wang X; Qiu S; Zhou J; Wang S; Zhang X; Shi Y; Figeys D; Ding L; Wang P; Zhang B; Rodriguez H; Gao Q; Gao D; Zhou H; Fan J
    Cancer Cell; 2022 Jan; 40(1):70-87.e15. PubMed ID: 34971568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand.
    Sa-Ngiamwibool P; Aphivatanasiri C; Sangkhamanon S; Intarawichian P; Kunprom W; Thanee M; Prajumwongs P; Loilome W; Khuntikeo N; Titapun A; Jareanrat A; Thanasukarn V; Srisuk T; Luvira V; Eurboonyanun K; Promsorn J; Wee A; Koonmee S
    HPB (Oxford); 2022 Nov; 24(11):1944-1956. PubMed ID: 35810105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.